NTLA · Intellia Therapeutics, Inc.
$10.92
-0.46 (-4.00%)
At close · Jul 20
Market Cap
$1.53B
Shares
139.72M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-06-30 | 12,334 | $16.61 | $204,868 |
| 2026-06-29 | 392 | $16.68 | $6,539 |
| 2026-06-26 | 9,858 | $16.03 | $158,024 |
| 2026-06-22 | 135,962 | $15.67 | $2,130,525 |
| 2026-06-18 | 15,456 | $15.20 | $234,931 |
| 2026-06-16 | 36,205 | $14.92 | $540,179 |
| 2026-06-15 | 346,521 | $12.11 | $4,196,369 |
| 2026-06-12 | 865 | $12.35 | $10,683 |
| 2026-06-08 | 12,063 | $13.54 | $163,333 |
| 2026-06-05 | 349 | $14.75 | $5,148 |
| 2026-06-04 | 2,229 | $13.02 | $29,022 |
| 2026-06-02 | 5,398 | $13.73 | $74,115 |
| 2026-06-01 | 15,992 | $14.07 | $225,007 |
| 2026-05-28 | 11,675 | $13.44 | $156,912 |
| 2026-05-22 | 109,705 | $12.37 | $1,357,051 |
| 2026-05-18 | 87 | $13.67 | $1,189 |
| 2026-05-14 | 18,575 | $14.28 | $265,251 |
| 2026-05-12 | 184 | $14.42 | $2,653 |
| 2026-05-06 | 1,208 | $13.31 | $16,078 |
| 2026-05-05 | 58,300 | $13.87 | $808,621 |
| 2026-05-04 | 1,247 | $13.26 | $16,535 |
| 2026-05-01 | 1,246 | $13.48 | $16,796 |
| 2026-04-30 | 190,818 | $12.45 | $2,375,684 |
| 2026-04-28 | 602,801 | $13.04 | $7,860,525 |
| 2026-04-24 | 27,013 | $15.87 | $428,696 |
| 2026-04-22 | 60,755 | $15.31 | $930,159 |
| 2026-04-21 | 531 | $15.21 | $8,077 |
Showing 1–27 of 27 settlements
Key facts
CIK
1652130
CUSIP
45826J105
13F (30d)
31 filings
31 filers
Visit website
Investor relations